Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01351558
Other study ID # 101.01
Secondary ID 10-093704
Status Terminated
Phase N/A
First received May 9, 2011
Last updated October 4, 2012
Start date May 2011
Est. completion date March 2012

Study information

Verified date October 2012
Source Frederiksberg University Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: The Capital Region of Denmark
Study type Interventional

Clinical Trial Summary

There is ample evidence that exercise therapy is beneficial with respect to pain in patients with osteoarthritis of the knee. However, the pain relieving mechanisms are unknown. To enhance the efficacy of exercise therapy a deeper understanding of the involved mechanisms is needed.

Different exercise types may affect the pain sensitivity differently. It is hypothesized that non-specific exercises (i.e. exercises that does not involve the knee) reduces the processing of pain in the central nervous system (central sensitivity) to knee joint pain in healthy subjects. It is also hypothesized that exercises that involve the knee (i.e. specific knee exercises) reduce the sensitivity of pain receptors in the knee (peripheral sensitivity) in healthy subjects.

Healthy volunteers are recruited and randomised to one of four interventions: 1: Muscle strengthening exercises involving the thigh muscles; 2: Muscle strengthening exercises involving the shoulder muscles; 3: Cardio-vascular fitness exercises; or 4: Control (no exercises). The active interventions include exercises three times per week for 12 weeks. Pain sensitivity and a range of explanatory variables is measured before the interventions, after 4 weeks and after 12 weeks.


Recruitment information / eligibility

Status Terminated
Enrollment 33
Est. completion date March 2012
Est. primary completion date March 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Age between 18 and 35 years

- Untrained (i.e. less than 2 hours of organised exercise per week in the last 6 months - physical activity related to transportation (e.g. bicycling) is not included)

- Generally healthy according a medical exam at screening, history

- Willing and able to participate in all measurements

- Willing and able to attend all training sessions

- Willing to keep the habitual activity and amount of training constant (ie screening activity and training volume).

- 20 = body mass index (BMI) = 28 kg/m2

- Speak, read and write Danish

Exclusion Criteria:

- Pregnant or breastfeeding

- Current or previous symptoms of autoimmune disease (eg, inflammatory bowel disease, multiple sclerosis, lupus, rheumatoid arthritis)

- Planned surgery during the study period

- Current or former musculoskeletal injuries or illnesses, including but not confined to:

- Ligament Injuries

- Meniscus Injuries

- Osteoarthritis

- Patellofemoral Pain Syndrome

- Backache

- Neck pain

- tendinopathy

- Current or past diagnosis, signs or symptoms of significant cardiovascular disease, including but not limited to:

- Ischemic heart disease

- Arteriosclerosis

- Medical conditions that contraindicate exercise, including but not limited to:

- Chronic or congenital heart disease

- Asthma

- Chronic Obstructive Pulmonary Disease

- Past or current diagnosis, signs or symptoms of significant neurological disease, in-incl. but not limited to:

- Blood clot in brain

- Stroke

- Clinically significant head trauma within the last year

- Peripheral neuropathy

- Epilepsy or seizures

- Impaired balance

- Alcohol or drug abuse within the past 5 years

- Past or current diagnosis, signs or symptoms of major psychiatric disorder

- Regional pain syndromes like fibromyalgia

- Regional pain caused by lumbar nerve root or cervical radiculopathy with or at risk for developing it

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Knee muscle strengthening exercises
Muscle strengthening exercises of the quadriceps and hamstring muscles will be performed based on a standard muscle strengthening exercise paradigm: 3 sets with 6-8 repetitions (corresponding to approximately 80% repetition maximum (RM)) will be performed. The training load will be progressed by means of weekly estimates of muscle strength to ensure a constant load of 80% RM. The exercises will be supervised
Upper extremity strengthening exercises
Muscle strengthening exercises of the upper amrs and shoulder girdle will be performed based on a standard muscle strengthening exercise paradigm: 3 sets with 6-8 repetitions (corresponding to approximately 80% repetition maximum (RM)) will be performed. The training load will be progressed by means of weekly estimates of muscle strength to ensure a constant load of 80% RM. The exercises will be supervised
Cardiovascular fitness exercises
Cardiovascular fitness exercises encompass circuit training including exercises on (but not limited to): ergometer cycles, treadmills (running), and cross-trainers. The exercise intensity is aiming at exercises within 60-85% of maximum heart rate (defined as 220 - age). The heart rate is monitored using a standard heart rate monitor. The exercises will be supervised

Locations

Country Name City State
Denmark The Parker Institute, Frederiksberg University Hospital Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Henning Bliddal

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in pressure pain sensitivity Baseline, and after 12 weeks of exercise No
Secondary Change in muscle strength Muscle strength is measured in knee extension and flexion and in arm extension and flexion (bench press and pull) baseline and after 12 weeks No
Secondary Change in cardiovascular fitness Watt max test is performed on a bicycle ergometer to estimate the maximal oxygen uptake velocity baseline after 4 weeks and after 12 weeks No
Secondary Change in baroreflex sensitivity Heart rate and blood pressure variability is measured during rest and during quiet standing. baseline after 4 weeks and after 12 weeks No
See also
  Status Clinical Trial Phase
Completed NCT02873143 - 5 Year Follow-up of Adolescents With Knee Pain N/A
Completed NCT00752765 - The Effects of Bariatric Surgery Weight Loss on Knee Pain in Patients With Osteoarthritis of the Knee N/A
Recruiting NCT05674604 - Cryoneurolysis for Knee and Shoulder Pain in an Inpatient Setting
Terminated NCT03171168 - The Effect of AposTherapy on Knee Pain N/A
Completed NCT05221047 - A Reliability and Validity Study of Urdu Version of Knee Outcome Survey-Activities of Daily Living Scale
Terminated NCT00601341 - Effects of Lumbosacral Joint Mobilization/Manipulation on Lower Extremity Muscle Neuromuscular Response N/A
Completed NCT03969654 - ROSA Robot Used in Total Knee Replacement Post Market Study N/A
Completed NCT03910036 - Effect of PRP Injection After Arthroscopic Meniscal Repair in the Healing Process Phase 4
Terminated NCT01764139 - Vitamin D Levels In Patients Who Has Normal to Grade 2 Knee Arthroscopy Changes N/A
Withdrawn NCT01112319 - The Effects of the Electro, Heat and Cold -Therapy During Physiotherapy Treatment in Osteoarthritis(OA) of KNEE Phase 1
Completed NCT00662493 - A Comparison of Two Exercise Programs on Knee Motor Control Phase 2
Completed NCT03956875 - Yoga for Aromatase Inhibitor-related Knee Pain Relief in Breast Cancer Patients N/A
Completed NCT03072108 - Dietary Supplement for Joint: the OLE Study N/A
Completed NCT00923598 - Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks Phase 4
Terminated NCT03970629 - ROSA Total Knee Investigational Testing Authorization Study N/A
Completed NCT00403273 - Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Arthroplasty (TKA) Phase 2
Completed NCT00745069 - Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis Phase 2
Completed NCT03815448 - Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis N/A
Recruiting NCT04084236 - The Effects of Transcutaneous Electrical Nerve Stimulation on People With Knee Osteoarthritis (OA) and or Chronic Pain N/A
Completed NCT05470244 - TENS in Post-operative Total Knee Arthroplasty Recovery and Intra-venous Analgesics Requirement N/A